MMF
Showing 26 - 50 of 917
Gout Chronic Trial in Birmingham (Pegloticase 8 MG/ML [Krystexxa], MMF, Placebo)
Completed
- Gout Chronic
- Pegloticase 8 MG/ML [Krystexxa]
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Mar 14, 2022
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023
GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)
Recruiting
- GATA2
- +2 more
- Allogeneic HSCT
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Mycophenolate Mofetil, Cyclophosphamide, Lupus Nephritis Trial in Changsha (Cyclophosphamide, Mycophenolate Mofetil)
Recruiting
- Mycophenolate Mofetil
- +2 more
- Cyclophosphamide
- Mycophenolate Mofetil
-
Changsha, Hunan, Chinathe Second Xiangya Hospital of Central South University
Aug 8, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Kidney Transplantation, Kidney Failure Trial in Zagreb (Mycophenolate mofetil)
Completed
- Kidney Transplantation
- Kidney Failure
- Mycophenolate mofetil
-
Zagreb, HR, CroatiaClinical Hospital Merkur
Oct 18, 2021
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022
Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,
Recruiting
- Immunodeficiency
- Hematopoietic Stem Cell Transplantation
- Post-Transplant Cyclophosphamide (PTCY)
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)
Not yet recruiting
- Stem Cell Transplantation
- Fludarabine
- +9 more
-
Houston, TexasM D Anderson Cancer Center
May 4, 2022
Patients Receiving MMF for Diffuse Cutaneous or Pulmonary
Recruiting
- Systemic Sclerosis
- AUC of MPA measure
-
Paris, FranceCochin hospital, AP-HP
Nov 19, 2021
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)
Recruiting
- Hematologic Malignancies
- CliniMACS® CD34 Reagent System
- +7 more
-
Chicago, Illinois
- +1 more
Sep 20, 2022
Kidney Transplantation, Kidney Transplant Rejection Trial in Los Angeles (Twice-daily Tacrolimus, Once-daily envarsus XR,
Recruiting
- Kidney Transplantation
- Kidney Transplant Rejection
- Twice-daily Tacrolimus
- +5 more
-
Los Angeles, CaliforniaUniversity of Southern California
Jun 6, 2022
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,
Active, not recruiting
- Chronic Myelogenous Leukemia
- +9 more
- tacrolimus
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021
Takayasu Arteritis Trial in China (MMF, CYC, Glucocorticoids)
Active, not recruiting
- Takayasu Arteritis
- MMF
- +4 more
-
Shijiazhuang, Hebei, China
- +6 more
Feb 26, 2022
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Leukemia
- +6 more
- Cyclophosphamide
- +8 more
- (no location specified)
Dec 8, 2021
AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)
Recruiting
- AML
- +8 more
- Clofarabine
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 13, 2022
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS Trial in Paris Cedex 10 (Autologous Hematopoietic Stem Cell Transplantation, Rituximab)
Withdrawn
- REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Autologous Hematopoietic Stem Cell Transplantation
- Rituximab
-
Paris Cedex 10, FranceDept. of Internal Medicine, Hôpital Saint-Louis
Sep 21, 2021
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Heart Transplantation Trial in New York (Belatacept, Tacrolimus, Mycophenolate Mofetil)
Recruiting
- Heart Transplantation
- Belatacept
- +3 more
-
New York, New YorkVallesky Berrich
Sep 17, 2021
Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)
Completed
- Kidney Transplantation
- +2 more
-
London, United KingdomWest London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021